/PRNewswire/ Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving.
New funding comprised of grants from the National Institutes of Health, The Andy Hill Cancer Research Endowment (CARE) Fund, and additional Equity FundingAdditional funding will support advancement of KayoThera’s development programs in diabetes and oncologySEATTLE (BUSINESS WIRE) KayoThera, Inc. (“KayoThera”), an.
/PRNewswire/ Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company, announced recent company updates to support its drug development.